John Fucci
Partner at Bios Partners
Fort Worth, Texas
Overview
Work Experience
Partner
2019 - Current
Bios Partners is a Venture Capital Firm identifying advanced biotech in overlooked and under-invested markets in the U.S., which our team helps cultivate and bring to market.
Vice President
2014 - 2019
Bios Partners is a Venture Capital Firm identifying advanced biotech in overlooked and under-invested markets in the U.S., which our team helps cultivate and bring to market.
Board Member
2025
Trefoil was founded to bring forward TTHX1114, a novel engineered FGF1 (eFGF1) compound to treat corneal diseases. Lead candidate TTHX1114 is an engineered form of naturally-occurring Fibroblast Growth Factor 1 (FGF1) designed to protect corneal endothelial cells and prevent vision loss by stimulating corneal endothelial cell proliferation and migration. Trefoil’s first product, currently undergoing clinical trials, is an intracameral injection of TTH1114 for the treatment of endothelial deficiencies. An intracameral injection involves the injection of a small amount of TTHX1114 into the eye (directly behind the cornea) using a very small needle. TTHX1114 has the potential to be the first pharmacologic treatment for corneal endothelial dystrophy, which puts patients at risk of vision threatening post-surgical edema which may lead to the need for a cornea transplant.
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
Raised $85,775,048.00 from Hatteras Venture Partners, Bios Partners, Correlation Ventures, Hatteras Venture Partners, Aju IB Investment, InFocus Capital Partners, Access Biotechnology and ExSight Ventures.
Board Member
2021 - 2024
SIRPant developed a cellular immunotherapy against cancer (SIRPant-M™) that promotes a polyclonal anti-tumor immune response that endures both in TIME (resulting in immune memory that prevents recurrence) and in SPACE (resulting in clearance of metastases) to achieve durable elimination of cancerous cells throughout the body.
Board Member
2017 - 2019
Lantern Pharma is leveraging A.I., machine learning & genomics to transform the cost, pace, and timeline of oncology drug discovery and development.
Vice President
2016 - 2019
Steelhead Capital Management is a family office located in Fort Worth, TX focused on investing in high growth opportunities in cryptocurrency, biotechnology, real estate, consumer packaged goods, etc.
Analyst
2013 - 2016
Steelhead Capital Management is a family office located in Fort Worth, TX focused on investing in high growth opportunities in cryptocurrency, biotechnology, real estate, consumer packaged goods, etc.
Steelhead Capital Management is a private equity firm that specializes in operational increment, strategic acquisitions, and organic growth.
President- Cowtown Angels Scholars Due Diligence Team
2013 - 2014
• Conducted due diligence for potential investment opportunities for the angel network • Proposed investment recommendations based on due diligence research • Focused specifically in financial analysis to determine feasibility and sustainability of prospective investments, and presented findings to the angel network, managed capitalization tables to understand ownership interests • Analyzed market opportunity, researched intellectual property protection, evaluated management team and explored the product feasibility
Student
2010 - 2014
M.J. Neeley School of Business, Class of 2014 Finance/ Real Estate Emphasis Entrepreneurial Management
Missiles and Fire Control Intern
2013 - 2013
• Reported directly to the Contract Negotiations Lead for the Ground Combat Vehicles area of Lockheed Martin Missiles and Fire Control, while conducting research efforts and contract management assignments • Managed contract revision reviews, while learning about key business aspects such as invitations to tender, proposals, authorizations, and definitizations of contracts • Through internal and external meetings, experienced financial aspects of the business and the correlation between Lockheed Martin, intermediary customers, and the U.S. and allied foreign governments
Lockheed Martin is a global security and aerospace company specialized in advanced technology systems, products and services.
Raised $62,016,440.00 from Air Force Research Laboratory, United States Air Force, NYSERDA and NYSERDA.
Finance Intern
2012 - 2012
• Realigned 45 GE sales representatives and created a database and map of all territories across the US in accordance with GE’s value proposition • Assisted sales team by contacting various customers across the US and performed rate exceptions, down payment reductions and term restructuring • Tested software application Touchless, a dealer interface, launched Oct. 1, 2012 • Created a GE TCU alumni network and an internal website; hosted a networking lunch with TCU Career Center
GE Commercial Finance is one of General Electric's largest growth engines.
Brokerage Intern
2011 - 2011
Established a database and contacted more than 3,000 potential clients, offered information on market conditions and available listings within our company Ran market surveys for 50 clients and identified purchase and lease opportunities that best fit their requirements Completed two industrial leases with clients within the Orange County marketplace Created marketing strategies for different listings based on the following criteria: competitors in the market, proximity to consumers and suppliers, and various other criteria
Lee & Associates Licensing and Administration is a real estate company.